Though an association has consistently been detected between recent aspirin intake and admission to hospital with hematemesis and/or melhna, the significance and the strength of the relationship have been contested. All available epidemiological data have compared the aspirin intake of the patients with bleeding with that of hospital in-patient or out-patient controls, but there are reasons for doubting whether such controls represent proper matches since they are not representative of the general population (Langman 1970) . A population control seems particularly necessary because the group with bleeding which has been most strongly associated with aspirin intake is that containing individuals without chronic ulcer disease, usually the radiologically negative or assumed acute erosion group. In addition a high proportion of those with chronic ulcer bleeding present for the first time with the bleeding episode and therefore are best matched with the ordinary population.
We have therefore compared the recent analgesic and other drug intake of patients admitted with hmmatemesis and meltena and the same drug intake of a random population sample.
The population control group was selected from two general practices in Nottingham, one from a relatively poor area and the other from a predominantly middle-class area, so that patients with bleeding could be matched with individuals of the same age, sex and social group drawn from one of the practices. The controls were not necessarily current attenders at their general practitioner, but were selected by taking the next individual of the same age and sex as the bleeding patient in a consecutive record card examination. Controls were contacted and asked to take part in a health survey without mentioning the specific objectives of questioning. A social worker (M E) then visited the control individual and asked the same questions as had been put to the patient with bleeding.
Results
So far 96 patients with bleeding and their matched controls have been questioned and Table 1 shows the overall frequency with which self-administered analgesic drugs were taken and also the frequency with which these and prescribed drugs, mainly anti-rheumatoid drugs, were taken. Uncertain, probably non-5 0 steroidal anti-rheumatoid More drugs were consistently taken by patients with bleeding than by their controls, and this was true both for prescribed and self-administered drugs. Table 2 shows the individual drugs prescribed. There was a higher proportion of patients with bleeding who took non-steroidal anti-rhematoid drugs (NSAR) and the difference is likely to be larger when all drugs taken have been definitely identified. No differences were found for corticosteroid intake; other differences, more takers of warfarin and of analgesic substances other than aspirin and paracetamol in patients than controls, were small. The significance of these differences is uncertain. Patient numbers are still small and therefore initial trends may not be maintained; however, the difference in NSAR consumption in the two groups already looks large. This could simply reflect a relative reluctance in our two control practices to use NSAR rather than a true association between bleeding and use of such drugs, but such an explanation seems unlikely. Table 3 compares the self-administered analgesic intake in the two days and the seven days before interview in the control group and before admission in the bleeding group. Again, there was a consistent tendency for patients with bleeding to have taken analgesic compounds more frequently than their controls. This tendency involved paracetamol as well as aspirin so that there were 13 aspirin takers in the bleeding group and 4 in the controls in the recent two days, a ratio of 3.3:1, but there were also 9 paracetamol takers in the bleeding group and 4 in the controls, a ratio of 2.25:1. Similarly, there were 24 aspirin takers in the bleeding group in the seven days before admission compared with 10 in the seven days before questioning in the control group, a ratio of 2.4:1. Again, there were more paracetamol takers in the bleeding group than in the controls, 12 and 7 respectively, a ratio of 1.7: 1.
Discussion
The greatest difference in drug intake in the prescribed drugs was found to be in non-steroidal agents. This may be confirmatory evidence to support what many doctors have suspected, that these compounds are capable of inducing acute gastrointestinal bleeding. On the other hand, because of the method of selection of controls it may only be a reflection of the prescribing habits of the two practices from which these controls were taken. The patients admitted with bleeding were referred from all round the area; the controls could have been from practices where such drugs are infrequently used. However, our suspicion is that there is a strong causal relationship which requires further study to determine its true importance.
From the data on self-administered preparations, it appears that there is an association with bleeding and aspirin ingestion. However, if there are reasons other than a direct causal relationship for aspirin taking to appear in the history, then it is logical to suppose that the same trend could appear with other analgesics. The obvious drug to use in testing such an hypothesis is paracetamol. Our data suggest an association between paracetamol intake and admission with bleeding Table 4 Reasons for analgesic and anti-inflammatory drug intake and if one accepts that paracetamol consumption is unlikely to cause acute upper gastrointestinal bleeding, then the paracetamol intake and presumably any other analgesic intake in the bleeding group could be an associated phenomenon rather than causal of bleeding.
Patients who present with acute gastrointestinal bleeding might take analgesic agents for all kinds of reasons, and Table 4 compares those given by our patients and controls. No clear trends yet emerge though there were more individuals in the bleeding group who took analgesics for indigestion than there were in the controls. Two differing deductions are possible: (1) That analgesic intake for indigestion precipitated bleeding. (2) That the lesion which caused the bleeding also caused indigestion and analgesic intake. Our data on paracetamol give some support for the second contention.
Conclusions
This investigation is incomplete and more case control comparisons will be needed before clear answers can be obtained. Analgesic consumption appears to be increased in patients presenting with acute bleeding but this is true for aspirin and for paracetamol, suggesting that aspirin consumption may not necessarily be causal of bleeding but an associated phenomenon. A second finding which may be important is the strength of the association between the taking of non-steroidal anti-rheumatic drugs and acute gastrointestinal bleeding, and this warrants further study.
DISCUSSION
Sir Richard Doll (Chairman): Professor Langman showed that there was an excess taking of analgesics by people with indigestion. There is a widespread belief that aspirin is of little use in indigestion which might account for the excess of paracetamol.
Professor Langman: At the moment we haven't analysed the data but we shall know later.
Dr Dawson, King's College Hospital: Paracetamol is not an anti-platelet agent, so how is it causing the bleeding? Professor Langman: I hope I didn't suggest that it did cause the bleeding. Most people would believe, possibly rightly, that, in comparison with aspirin, paracetamol doesn't cause bleeding, although much of the evidence cited against aspirin could also be cited against paracetamol. I was using it as a positive drug control to look for some sort of systemic change.
Mr Sutherland, Miles Laboratories: Would Professor Langman and Professor Piper comment on the symptoms which would precede hmmatemesis, or could be associated with a patient suffering known gastric pathology? The two sets of controls seemed not to have a similar health status. It seems to be clearly possible that a set of symptoms associated with known pathology or a hematemesis could well have made the consumption of an analgesic a wholly normal or anticipated activity. Does that perhaps explain the higher intake of those two patient categories?
Professor Piper: Our control group with the bleeds was selected on the next emergency admission matched for age and sex. Both groups had a diseaseone had bleeding of the gastrointestinal tract, the other group had pneumonia, asthma, etc.
Professor Langman: In the first half of our study one-quarter of the controls were taking antacids on a regular basis, so presumably there is high incidence of dyspepsia. This is well known, as shown in a study done at the Central Middlesex Hospital by Sir Richard Doll.
Dr Grayson, North Middlesex Hospitals: Some of today's arguments remind me of some of the attempts by people who don't believe that smoking causes lung cancer to demolish extremely good statistical evidence of an association. Perhaps our Chairman would comment on this, since he has an interest in it.
Secondly, I think there is an inconsistency. Professor Piper reported that an increased intake of analgesics was not associated with bleeding in patients with acute gastric erosion, but Professor Langman stated on one or two occasions, that this was a known and recognized association. Finally, would Professor Piper, who has told us that he regards bleeding to be associated with chronic ulceration rather than with analgesic intake, recommend that a patient with a chronic peptic ulcer be given aspirin? Alternatively, would he, like most clinicians, still hold back from this? Sir Richard Doll: Professor Bradford Hill laid down nine criteria to be fulfilled when trying to decide whether an association obtained epidemiologically between a disease and an etiological agent is likely to be a causal one or not. Six of these were satisfied at the time Professor Bradford Hill went on record as concluding that smoking was the cause of lung cancer. That is not in any way inconsistent with the use of the criteria that he put forward. They were never meant to be anything more than indications of the sort of evidence that should be looked for and he pointed out that in the middle of the last century a number of quite able observers were putting on record the fact that the development of typhus in ships taking people out to Australia had some unknown cause, definitely unrelated to the parasites that the immigrants had, as has been suggested by someone else. In other words, whether an association is biologically plausible or not depends on the current state of knowledge and the demonstration of an association between the agent and the disease may be the first indication that it is plausible. One criterion, in particular, which was not satisfied in relation to lung cancer was specificity. Smoking appeared to be related to several different diseases, and it is now possibly causally related to ten or so. The fact that the relationship was not specific is a reason for casting a little doubt, but not for throwing it out. Bradford Hill pointed out that one might as well conclude that milk was not likely to be a medium which carried infectious agents because it caused typhoid, diphtheria and tuberculosis. Ergo it could not cause any of them! I have no doubt that, even from the beginning, the indications that the relationship between smoking and lung cancer was a causal one was very much stronger than the evidence at present relating to the use of aspirin and gastrointestinal heemorrhage.
Professor Piper: In our series there was a similar analgesic intake pattern in the acute bleed group as in controls, but the numbers in the acute bleed group were small, which makes it difficult to be dogmatic. Secondly, in the past we have always said that chronic gastric ulcer patients should avoid all analgesics. Based on the evidence we presented this morning, the course of an ulcer is determined more by whether it has completely healed before leaving hospital, rather than by analgesic intake. If the ulcer has completely healed up, then analgesic intake exerts no adverse effect; but in the unhealed ulcer, heavy analgesic intake has an adverse effect over four years.
Professor Langman: The data on acute erosions which were collected some ten years ago all suggested that there was a group of patients who had aspirin bleeds, who were X-ray negative, and they were assumed to have acute erosions. Circumstances may be overtaking us in that investigation is now more intensive, and it looks as though many of these patients may never have had acute erosions at all. This may be where the inconsistency arises.
The other point about whether one is trying to whitewash aspirin is fair comment. I don't think so, because my proposition has been that at the moment I would not seek to deny there was any association, only that it is unlikely to be as strong as has been suggested in the past. Dr Morley: In asthma, a small proportion of patients are sensitive to aspirin and aspirin is held to be a causative factor in the disease. I doubt that this conclusion would be drawn if one did an epidemiological study of the type that has been discussed this morning, by taking the asthma population as a whole and consulting them with respect to their aspirin ingestion. This conclusion has been arrived at simply by challenging the patients to aspirin and I don't think there is any doubt that this phenomenon exists. Might it not therefore be possible that a similar phenomenon exists with respect to gastrointestinal bleeding? There is a small population who are sensitive to the drug and population studies of the sort described would not pick this out and recourse would have to be made to using challenge situationswhich may be ethically impossibleto come to this conclusion.
Dr Fryers: The studies that have been done on the consistency criterion of Bradford Hill, i.e. whether people who had a bleed once will have it again, shows that they do not. All the studies which have been done, as far as I am aware, have failed to show that the condition was reproducible in the same people, and there must be very large numbers of people who have taken aspirin again.
Consistency is one of the major reasons for questioning the cause-and-effect relationship as postulated, because the people who have bled have taken aspirin on very many occasions before the occasion on which they are supposed to have bled and, unlike smoking, there is no suggestion of a cumulative effect. Many of them, after admission to hospital, are not taking aspirin but may re-bleed a week to ten days after admission, perhaps two weeks after their last dose of aspirin.
Nobody knows of any mechanism to explain that sort of thing, and nobody knows of any evidence that these people bleed again when they subsequently take aspirin. Dr Goodall, Miles Laboratories: A year or so ago, I researched the literature on this subject very thoroughly for presentation to the CRM and there is no evidence that the patients who have been admitted with an acute upper gastrointestinal bleed, reportedly caused by aspirin, have, on re-challenge, shown any more occult blood loss than would be expected from a control patient. Every piece of evidence where this has been tried indicates that it is not a reproducible hypersensitivity to aspirin. Professor Langman: I have no useful impression at all as I don't conventionally bother to tell my patients not to take aspirin, because I don't think the evidence is good enough. Sir Richard Doll: I think we take it that this meeting agrees that there is no evidence that a person who has had a massive hemorrhage, possibly causally related to ingestion of aspirin, is any more likely to bleed again when taking further aspirin than an average member of the population.
Dr Goodall: I would like to make one more remark about controls. When one asks about various symptoms, e.g. have they taken their aspirin for headache, indigestion, colds or 'flu, no studies have looked carefully enough at whether the patients take their aspirin for the prodromal symptoms of the bleed. One study stated that in the investigator's opinion some patients had taken aspirin for symptoms which could have been caused by gastrointestinal hmmorrhage.
Professor Langnan: There is no way of being certain that this is correct or not and you end up with an ex cathedra judgment.
Professor Piper: Almost any symptom could be the first sign of a bleedfeeling tired, weak, giddy, headaches and so on.
Dr Fryers: A recent Mayo Clinic paper categorically states that aspirin had not been taken for gastrointestinal symptoms.
Sir Richard Doll: One of the striking observations in Professor Piper's series was that none of the control women had said they had been taking aspirin daily, and this contributed very largely to the difference observed between the gastric ulcer and the control patient. On the other hand a substantial proportion of the men said they had been taking aspirin daily. On the biochemical tests, more women than men showed that they had taken aspirin in the last 24 hours. In view of the fact that gastric ulcer in women is the characteristic disease in Australia, and the habit of taking commercial powders is so common in women in Australia, do you think the figure of zero daily takers is in fact a reliable figure?
Professor Piper: The figures have been checked and appear to be true, i.e. none of the 79 controls admits to taking analgesics daily, which is surprising.
Dr Abrahams, National Hospital: Has any association been reported between aspirin overdosage and acute gastrointestinal hemorrhage? Secondly, is there any relationship between aspirin intake and anemia, or in terms of occult blood in the stool. Finally, what analgesic would the speakers recommend as a non-specific, antipyretic analgesic? Dr Fryers: One or two centres, particularly Edinburgh, which have made a special study of people who have taken overdoses of all sorts of things, have checked back through their records and found a large number of people admitted with large overdoses of aspirin. The stomachs of all of them had been washed out and none was recorded to have any blood present in the washouts.
Dr Elliot, Miles Laboratories: I have seen actual moulds of the stomach at post-mortem consisting solely of analgesics, with no history of bleeding. Dr Fryers: With regard to anemia there is undoubtedly variable blood loss after taking aspirin, which is often now referred to as seepage rather than bleeding, but we don't know where it arises from or just what is happening. However, it is certainly quite different from massive hemorrhage, and in some people who are marginally deficient in their iron intake it must occasionally push them over the top.
Professor Piper: If you believe this morning's evidence that aspirin does not cause acute bleeds, and does not adversely affect the course of the healed ulcer, you could prescribe it liberally. If you are going to show some caution, then soluble aspirin given with meals may be safer than other forms.
Sir Richard Doll: Professor Langman showed, in a ten year period, an increase of over 30% in hospital admissions for acute upper gastrointestinal hkmorrhage of unidentified cause. I doubt very much if total hospital admissions have increased by that amount, and it might just be that patients are being sent to hospital more easily. In the early 1950s perforations of peptic ulcer were decreasing, but I don't know if they have continued to decrease over the past ten years. If it were a fact that htmorrhage from chronic ulcer was decreasing at the present time, it would emphasise the importance of the clinical problems not attributable to chronic ulcer.
Professor Langman: The General Register Office provides information about admissions for chronic ulcer, and for perforated ulcer, but not for ulcer bleeding. Overall admissions for gastric ulcer have fallen by about 40% in the last ten years, and admissions for perforated ulcers have fallen by about 50%; admissions for duodenal ulcers have fallen by between 10 and 15%. I don't know of anything to suggest that bleeding ulcer differs in any way. The difficulty with this is that the diagnostic criteria now employed are different from those employed 10 or 15 years ago; for instance there is a great deal more duodenal ulcer simply because we look, rather than relying on barium impressions. Dr Goodall: Those figures only relate to admissions and not to outpatients. The fall in admissions may very well reflect the increase in the number of gastric ulcer patients who are now quite adequately treated at home by their GPs.
Professor Langman: Two reasons why you may be wrongfirstly perforation rates have fallen, which is probably a fair index of actual ulcer frequency, and secondly effective treatments for gastric ulcer became available about 1966/67, at which stage the admission rate for gastric ulcer was already falling. It may have been decreased further because of new treatments, but frankly I doubt it. Dr Wilson, Middlesex Hospital: Has there been any increase in the expected incidence of bleeding in patients taking aspirin daily in the various trials of thrombosis prevention?
Dr Fryers: In a related large-scale Australia/NZ study of over 1000 rheumatoid arthritics who were taking very large doses of aspirin there was quite a low incidence of bleeding, roughly comparable to the rest of the population. I don't know any reports of increased incidence of bleeding as a complication of prophylaxis.
Dr Sweetnam, MRC Epidemiology Unit: In our first trial, carried out by Dr Elwood, there were either two or three cases of bleeding among about 1500 men followed for an average of 18 months. However, they were only taking one aspirin tablet per day (about 300 mg) which is rather smaller than most of the other trials.
Dr Grayson, North Middlesex Hospital, London: As a rheumatologist I feel that the incidence of aspirin-induced occult bleeding anaemia in rheumatoid patients is higher than the speakers have indicated. For example, in a survey I did some time ago, on rheumatoid arthritic patients with a heemoglobin below a certain level, four out of 23 patients were quite severely iron deficient and had strongly positive occult blood tests on many occasions. They were not exclusively taking aspirin, but many different nonsteroidal anti-inflammatory drugs. It is general experience in rheumatology practice, that occult blood loss is quite a common cause of anemia in rheumatoid patients, who are perhaps a special group with more liability to this. Dr Elliot, Miles Laboratories: What is your experience with acute heamorrhage in the same patients ?
Dr Grayson: I have seen very few acute bleeds in patients taking non-steroidal anti-inflammatory drugs, although of course one always sees a few on any drug. My impression is that it is not an enormous risk with these patients, even on high doses over long periods of time, whereas the development of anemia, part of which is due to occult bleeding, seems to be more of a problem.
Dr Elliot: Are you sure that there is a specific iron deficiency due to bleeding, or is there not also an anemia associated with the rheumatoid process per se ?
Dr Grayson: The survey I mentioned was with 23 patients drawn from a large outpatient clinic who were anamic. Four were grossly iron deficient and the others had anxmia due to poor iron utilization, hemolysis and other causes known to occur in rheumatoid arthritis. Clearly iron deficiency is one, but not a major factor in the anaemia of rheumatoid arthritis, but in these particular four patients iron deficiency due to occult bleeding was the major cause.
Dr Barker, Medistat: Could I make two suggestions for any further work? First, urinalysis should be carried out on the controls and the patients to make sure that their aspirin and paracetamol status is as accurate as we can make it. Secondly, in the same urinalysis the vitamin C status in both groups should be estimated. It is well known that a low level of ascorbic acid leads to capillary fragility and we may be dealing with patients who have had a low ascorbic acid level for some considerable time. I believe there is now some published evidence to show that males and females differ in their response to ascorbic acid.
Professor Piper: In the chronic ulcer population we have collected a urine specimen at 8 p.m., the patient not knowing the reason for its collection, and we have looked for analgesics and alcohol, but your point about ascorbic acid is a good one.
